跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LIVMARLI 9,5 MG/ML SOLUCION ORAL - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LIVMARLI 9,5 MG/ML SOLUCION ORAL
Approved
STANDARD
LIVMARLI 9,5 MG/ML SOLUCION ORAL
Mirum Pharmaceuticals International B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 24, 2023
Approval ID
efff6cdc0eedd4cc
Company
Mirum Pharmaceuticals International B.V.
Type
Standard
Approval Details
Approval Id
efff6cdc0eedd4cc
Drug Cima Aemps Name
LIVMARLI 9,5 MG/ML SOLUCION ORAL
Register Number
1221704001
Holder Company Name
Mirum Pharmaceuticals International B.V.
Marketing Company Name
Mirum Pharmaceuticals International B.V.
Holder Company Detail Path
/organization/mirum-pharmaceuticals-international
Marketing Company Detail Path
/organization/mirum-pharmaceuticals-international
Authorization Date
2023-03-24
Dosage Form
SOLUCIÓN ORAL
Dose
9,5 MG/ML
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Mirum Pharmaceuticals International B.V.
Company Detail Path
/organization/mirum-pharmaceuticals-international
Company Information
Pharmaceutical Company Name
Mirum Pharmaceuticals International
Country Name
Belgium
City Name
unknown,unknown,country_be
Address
Unknown Belgian address
Active Ingredients
MARALIXIBAT CLORURO DE
300 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 24, 2023
Approval ID
efff6cdc0eedd4cc
Type
Standard
Back to CIMA-AEMPS Approvals